全文获取类型
收费全文 | 61737篇 |
免费 | 5509篇 |
国内免费 | 4049篇 |
专业分类
耳鼻咽喉 | 524篇 |
儿科学 | 808篇 |
妇产科学 | 1069篇 |
基础医学 | 7904篇 |
口腔科学 | 981篇 |
临床医学 | 7986篇 |
内科学 | 9640篇 |
皮肤病学 | 701篇 |
神经病学 | 3678篇 |
特种医学 | 2283篇 |
外国民族医学 | 52篇 |
外科学 | 6300篇 |
综合类 | 8157篇 |
现状与发展 | 19篇 |
一般理论 | 3篇 |
预防医学 | 4105篇 |
眼科学 | 1705篇 |
药学 | 6459篇 |
78篇 | |
中国医学 | 3083篇 |
肿瘤学 | 5760篇 |
出版年
2024年 | 736篇 |
2023年 | 1266篇 |
2022年 | 2453篇 |
2021年 | 3151篇 |
2020年 | 2389篇 |
2019年 | 2146篇 |
2018年 | 2237篇 |
2017年 | 1888篇 |
2016年 | 1895篇 |
2015年 | 2695篇 |
2014年 | 3331篇 |
2013年 | 2813篇 |
2012年 | 4432篇 |
2011年 | 4894篇 |
2010年 | 2956篇 |
2009年 | 2250篇 |
2008年 | 3116篇 |
2007年 | 3214篇 |
2006年 | 3155篇 |
2005年 | 3138篇 |
2004年 | 2130篇 |
2003年 | 2065篇 |
2002年 | 1783篇 |
2001年 | 1258篇 |
2000年 | 1322篇 |
1999年 | 1413篇 |
1998年 | 934篇 |
1997年 | 887篇 |
1996年 | 675篇 |
1995年 | 626篇 |
1994年 | 509篇 |
1993年 | 332篇 |
1992年 | 421篇 |
1991年 | 371篇 |
1990年 | 334篇 |
1989年 | 290篇 |
1988年 | 298篇 |
1987年 | 240篇 |
1986年 | 232篇 |
1985年 | 182篇 |
1984年 | 127篇 |
1983年 | 98篇 |
1982年 | 54篇 |
1981年 | 52篇 |
1980年 | 40篇 |
1979年 | 97篇 |
1978年 | 41篇 |
1975年 | 40篇 |
1974年 | 52篇 |
1973年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
121.
Kitala Diana Klama-Baryła Agnieszka Misiuga Marcelina Łabuś Wojciech Kraut Małgorzata Szapski Michał Lesiak Marta Krakowian Daniel Sieroń Aleksander L. Łos Marek J. Kucharzewski Marek 《Archivum immunologiae et therapiae experimentalis》2019,67(3):189-196
Archivum Immunologiae et Therapiae Experimentalis - Stem cells are increasingly being used in the course of burn treatment. As several different types of stem cells are available for the purposes,... 相似文献
122.
Yanfen Zhang Ruocen Bai Chong Liu Chunyan Ma Xin Chen Jun Yang Dandan Sun 《Clinical genetics》2019,95(4):451-461
Diabetes mellitus (DM) has become the third major chronic non-communicable disease affecting global public health, following cancer and cardiovascular and cerebrovascular diseases. Although previous studies have found a correlation between microRNA (miRNA) and the development of DM, thus far, most reviews have focused on the studies describing the changes in miRNA expression profiles and the mechanisms by which miRNAs-induce DM. However, reviews summarizing the effect of miRNA single-nucleotide polymorphisms on the developmental stages of DM and its complications are still needed. Studies on the variation of miRNAs will not only help to further understand the role that genetic factors play in DM, but will also have important implications for treatment and disease prognosis. 相似文献
123.
J. Jiao Y. Jin M. Zheng H. Zhang M. Yuan Z. Lv W. Odhiambo X. Yu P. Zhang C. Li Y. Ma Y. Ji 《Clinical and experimental immunology》2019,195(2):190-201
Diffuse large B cell lymphoma (DLBCL) is traced to a mature B malignance carrying abnormal activation-induced cytidine deaminase (AID) expression. AID activity initially focuses on deamination of cytidine to uracil to generate somatic hypermutation and class-switch recombination of the immunoglobulin (Ig), but recently it has been implicated in DNA demethylation of genes required for B cell development and proliferation in the germinal centre (GC). However, whether AID activity on mutation or demethylation of genes involves oncogenesis of DLBCL has not been well characterized. Our data demonstrate that the proto-oncogene Fanconi anaemia complementation group A (FANCA) is highly expressed in DLBCL patients and cell lines, respectively. AID recruits demethylation enzyme ten eleven translocation family member (TET2) to bind the FANCA promoter. As a result, FANCA is demethylated and its expression increases in DLBCL. On the basis of our findings, we have developed a new therapeutic strategy to significantly inhibit DLBCL cell growth by combination of the proteasome inhibitor bortezomib with AID and TET2 depletion. These findings support a novel mechanism that AID has a crucial role in active demethylation for oncogene activation in DLBCL. 相似文献
124.
125.
Qingsong Huang Zhiguo Niu Jing Tan Jun Yang Yun Liu Haijun Ma Vincent W.S. Lee Shuming Sun Xiangfeng Song Minghao Guo Yiping Wang Qi Cao 《Journal of the American Society of Nephrology : JASN》2015,26(9):2199-2211
IL-25 is an important immune regulator that can promote Th2 immune response-dependent immunity, inflammation, and tissue repair in asthma, intestinal infection, and autoimmune diseases. In this study, we examined the effects of IL-25 in renal ischemic/reperfusion injury (IRI). Treating IRI mice with IL-25 significantly improved renal function and reduced renal injury. Furthermore, IL-25 treatment increased the levels of IL-4, IL-5, and IL-13 in serum and kidney and promoted induction of alternatively activated (M2) macrophages in kidney. Notably, IL-25 treatment also increased the frequency of type 2 innate lymphoid cells (ILC2s) and multipotent progenitor type 2 (MPPtype2) cells in kidney. IL-25–responsive ILC2 and MPPtype2 cells produced greater amounts of Th2 cytokines that associated with the induction of M2 macrophages and suppression of classically activated (M1) macrophages in vitro. Finally, adoptive transfer of ILC2s or MPPtype2 cells not only reduced renal functional and histologic injury in IRI mice but also induced M2 macrophages in kidney. In conclusion, our data identify a mechanism whereby IL-25-elicited ILC2 and MPPtype2 cells regulate macrophage phenotype in kidney and prevent renal IRI. 相似文献
126.
Mutations within the major hydrophilic region (MHR) of Hepatitis B virus from individuals with simultaneous HBsAg and anti‐HBs in Guangzhou,Southern China 下载免费PDF全文
Kemin Liu Mingyu Xie Xiaomei Lu Hui Yu Hui Wang Yunjian Xu Qingqing Yang Yongping Lin Qiang Ma 《Journal of medical virology》2018,90(8):1337-1342
127.
Magdalena Zasada Marzena Lenart Magdalena Rutkowska-Zapała Małgorzata Stec Nina Mól Ola Czyz Maciej Siedlar Przemko Kwinta 《Immunobiology》2018,223(1):18-24
Background
Inflammasomes regulate activation of caspase-1, which cleaves and activates interleukin (IL)-1β and IL-18, the cytokines that trigger pro-inflammatory and antimicrobial responses. There is very little known about inflammasome function in the subsets of monocytes (MO) isolated from preterm neonates born extremely and very prematurely.Methods
A group of 76 very low birth weight patients without early-onset sepsis was divided into extremely preterm (<28 gestational week) or very preterm (28–32 gestational week) neonates. The first blood sample was collected on the 5th day of life (5th DOL) to analyse MO subsets as well as the intracellular IL-1β expression and supernatant concentration of IL-1β and IL-18. Secondary blood samples were collected within 24 h of late-onset sepsis (LOS) development and analysed as above.Results
On the 5th DOL, the extremely preterm neonates were characterized by a significantly higher absolute count of MO, in particular in the classical and intermediate subsets, as compared to the very preterm group. The counts of the intermediate and non-classical MO subsets increased during LOS in all neonates. We did not observe significant differences in the intracellular IL-1β expression between the analysed groups. Furthermore, the levels of the analysed cytokines in the MO supernatants were comparable between the extremely and very preterm neonates on the 5th DOL. Finally, a higher level of IL-18 was observed in the supernatant of the extremely preterm group during LOS.Conclusions
During LOS, extremely preterm neonates excrete a higher level of IL-18 cytokines compared to very preterm neonates. Further studies are required to determine whether this observation is a result of a higher count of the circulating MO or is a true reflection of increased inflammasome function in this particular group of newborns. 相似文献128.
Amin Zhang Jie Yu Shuxin Yan Xia Zhao Chen Chen Ying Zhou Xueyun Zhao Mingqiang Hua Ruiqing Wang Chen Zhang Chaoqin Zhong Na He Chunyan Ji Daoxin Ma 《Human immunology》2018,79(1):57-62
NLRP3 inflammasome has been recently reported as an important risk factor in the development of cancer. But the relationship between polymorphisms of NLRP3 inflammasome related genes and chronic myeloid leukemia (CML) is rarely reported. Therefore, the aim of the present study was to investigate the association of five genetic polymorphisms (NLRP3, IL-1β, IL-18, CARD8 and NF-κB) in 267 CML patients and 344 healthy controls. We found that the AT genotype of CARD8 (rs2043211) was significantly higher compared to TT genotype in high and intermediate risk CML patients. IL-1β (rs16944) polymorphism in early molecular response at 6?months was marginally different, with more GG and less AA genotype in BCR-ABLIS >1% group. IL-18 (rs1946518) polymorphism was significantly different with more GG genotype in BCR-ABLIS >1% group at 6?months. We also demonstrated that WBC count of newly diagnosed patients carrying AG genotype was significantly higher than that of GG or AA genotype of IL-1β (rs16944). The onset age of patients carrying ins/ins genotype of NF-κB (rs28362491) was significantly older than that of ins/del and del/del genotype. Moreover, IL-1β or NLRP3 mRNA expression was decreased and IL-18 mRNA expression was increased significantly in CML patients compared with controls. In conclusion, the genetic polymorphisms of NLRP3 inflammasome may be served as potential predictors for CML. 相似文献
129.
Zhendong Zhu Jiyun Ye Yumei Ma Peng Hua Yu Huang Xuemei Fu Dexuan Li Maogen Yuan Zhonghua Xia 《Human immunology》2018,79(7):564-570
T regulatory type 1 (Tr1) cells can promote tolerance and suppress inflammation. Atherosclerosis may be induced by the proinflammatory activation of cells in the vasculature and the immune system. Hence, we wondered whether defects in Tr1 function were a contributing factor to coronary artery disease (CAD). Data showed that the frequency of IL-10+ Tr1 cells was significantly lower in CAD patients than in controls. Compared to healthy controls, Tr1 cells from CAD patients presented lower CTLA-4 but higher PD-1 expression, in addition to lower IL-10 secretion. When co-incubated with Tconv cells, the CD4+CD49b+LAG-3+CD45RO+ Tr1 cells presented IL-10-dependent inhibitory effects, and those from CAD patients presented significantly lower suppression capacity than those from healthy controls. Interestingly, the characteristics of Tr1 cells were associated with clinical features of CAD patients. The frequency of Tr1 cells and the IL-10 and LAG-3 expression by Tr1 cells were negatively correlated with the BMI of the CAD patients. In addition, the Tr1 frequency and the LAG-3 and CTLA-4 expression on Tr1 cells were lower in CAD patients with higher numbers of narrowed vessels. Together, these results suggest that in CAD, Tr1 cells present multiple defects, which are associated with the clinical presentation of the disease. 相似文献
130.
Leigh syndrome (LS) is an inherited mitochondrial encephalopathy associated with gene mutations of oxidative phosphorylation pathway that result in early disability and death in affected young children. Currently, LS is incurable and unresponsive to many treatments, although some case reports indicate that supplements can improve the condition. Many novel therapies are being continuously tested in pre‐clinical studies. In this review, we summarize the genetic basis of LS, current treatment, pre‐clinical studies in animal models and the management of other mitochondrial diseases. Future therapeutical strategies and challenges are also discussed. 相似文献